Business Context and Reporting Period
This Form 8-K was filed by Deep Medicine Acquisition Corp. on October 20, 2022, reporting events occurring primarily on October 15, 2022. The company is a special purpose acquisition company (SPAC) seeking to consummate an initial business combination. The filing does not provide operating information for Trugolf Holdings, Inc.
Material Financial and Corporate Developments
- Extension financing: On October 15, 2022, the company issued two non-interest-bearing promissory notes totaling $1.265 million to affiliates of its sponsor, Bright Vision Sponsor LLC.
- Trust account deposit: On October 19, 2022, the full $1.265 million was deposited into the company’s trust account. The amount will be included in distributions to public shareholders upon liquidation or in the redemption amount for shareholders electing redemption in connection with the initial business combination.
- Repayment: The notes are repayable in full upon the earlier of completion of the initial business combination or liquidation of the company.
- Business combination deadline: The company extended its deadline to complete a business combination from October 29, 2022, to January 29, 2023.
Management Changes and Commentary
- Directors Bryant E. Fong and Marc A. Hamer resigned effective October 15, 2022, citing personal reasons and stating that their resignations were not due to disagreements with the company.
- John Chiang was appointed to the Board effective immediately and became chairman of the audit committee and compensation committee.
- The filing states that Mr. Chiang had no disclosed family relationships or related-party transactions requiring disclosure under Item 404(a) of Regulation S-K.
- The company issued a press release on October 20, 2022, announcing the extension.
Financial Metrics, Liquidity, and Risks
The filing does not provide revenue, profit, cash flow, margins, debt balances other than the $1.265 million notes, or other operating financial metrics. The notes create a direct financial obligation, although they bear no interest. The extension remains subject to the company’s ability to complete an initial business combination by January 29, 2023; otherwise, the company may be required to liquidate and distribute available trust-account funds to public shareholders, subject to applicable terms.
Most Important Facts to Verify
- Whether the company completed an initial business combination by the extended January 29, 2023 deadline.
- Whether the $1.265 million sponsor-affiliate notes were repaid upon a business combination or liquidation.
- The actual amount ultimately available per public share from the trust account after redemptions, expenses, and other obligations.
- The relationship, if any, between this SPAC filing and Trugolf Holdings, Inc.; this filing text does not identify Trugolf as the registrant or provide transaction terms involving Trugolf.